Search

Author/Creator Castro-Labrador, Laura

1. CRISPR/Cas9-mediated glycolate oxidase disruption is an efficacious and safe treatment for primary hyperoxaluria type I. Issue 1 (December 2018)

Authors:
Zabaleta, Nerea; Barberia, Miren; Martin-Higueras, Cristina; Zapata-Linares, Natalia; Betancor, Isabel; Rodriguez, Saray; Martinez-Turrillas, Rebeca; Torella, Laura; Vales, Africa; Olagüe, Cristina; Vilas-Zornoza, Amaia; Castro-Labrador, Laura; Lara-Astiaso, David; Prosper, Felipe; Salido, Eduard...
Journal:
Nature communications
Issue:
Volume 9:Issue 1(2018)
Page Start:
1
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. Single-Cell RNA Sequencing Analysis Reveals a Crucial Role for CTHRC1 (Collagen Triple Helix Repeat Containing 1) Cardiac Fibroblasts After Myocardial Infarction. Issue 19 (10th November 2020)

Authors:
Ruiz-Villalba, Adrián; Romero, Juan P.; Hernández, Silvia C.; Vilas-Zornoza, Amaia; Fortelny, Nikolaus; Castro-Labrador, Laura; San Martin-Uriz, Patxi; Lorenzo-Vivas, Erika; García-Olloqui, Paula; Palacio, Marcel; Gavira, Juan José; Bastarrika, Gorka; Janssens, Stefan; Wu, Ming; Iglesias, Elena; ...
Journal:
Circulation
Issue:
Volume 142:Issue 19(2020)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. Spatially resolved proteomic profiling identifies tumor cell CD44 as a biomarker associated with sensitivity to PD-1 axis blockade in advanced non-small-cell lung cancer. Issue 8 (24th August 2022)

Authors:
Moutafi, Myrto K; Molero, Magdalena; Martinez Morilla, Sandra; Baena, Javier; Vathiotis, Ioannis A; Gavrielatou, Niki; Castro-Labrador, Laura; de Garibay, Gorka Ruiz; Adradas, Vera; Orive, Daniel; Valencia, Karmele; Calvo, Alfonso; Montuenga, Luis M; Ponce Aix, S; Schalper, Kurt A; Herbst, Roy S;...
Journal:
Journal for immunotherapy of cancer
Issue:
Volume 10:Issue 8(2022)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗